Publication | Closed Access

Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial

VaccinationHematological MalignancyChronic Myeloid LeukaemiaMedicineHematologyImmunologyVaccine TrialMyeloid NeoplasiaP210 Multipeptide VaccineImmunotherapyOncologyRadiation OncologyPersistent Residual DiseaseHealth Sciences